Leading tuberculosis and infectious diseases expert Professor Jon Friedland has been appointed as Deputy Principal (Research and Enterprise) at St George’s, University of London.

calendar-icon 25 May 2018

Professor Friedland joins St George’s from Imperial College London, where he has held research, teaching and leadership positions for more than two decades. His new role marks a return to St George’s, where he previously completed his PhD.

Principal Professor Jenny Higham said: “We are delighted to welcome Jon back to St George’s. He brings with him an outstanding combination of research, leadership and clinical expertise, which I know will benefit the university enormously as we progress our ambitious research and enterprise plans.”

“Jon will be a key member of the St George’s senior management team, playing a vital role in the university’s leadership and working closely with senior academic and professional services colleagues.”

In his role as Deputy Principal (Research and Enterprise) at St George’s, he will be responsible for developing and delivering a major portion of the university’s strategy.  

Professor Friedland will focus on increasing research and enterprise income, enhancing the research culture and environment, and developing partnerships, which will include building on the university’s strong link with the St George’s University Hospitals NHS Foundation Trust.

Professor Friedland said: “I am very much looking forward to returning to St George’s to develop and strengthen research and enterprise activities. It is an exciting time in the development of the university, with a fresh leadership team, a new strategy in place and huge potential which we need to realise.”

He will take up his role at St George’s in September 2018. Alongside his leadership responsibilities, he will continue his research into infectious diseases, bringing with him his current scientific team. He will also hold an honorary clinical contract with St George’s University Hospitals NHS Foundation Trust.

About Professor Friedland

Professor Friedland is currently Hammersmith Campus Director and Head of Infectious Diseases and Immunity at Imperial College London. His research interests focus on tuberculosis, in particular how to target the immune system’s inflammatory response which causes tissue damage leading to patient morbidity and mortality. He also has a longstanding interest in migrant health, especially in relation to infectious diseases. During his career, he has published 217 peer reviewed papers and edited three books.

Graduating in medicine from Cambridge University and King’s College London, Professor Friedland has remained clinically active throughout his career and is currently a consultant in infectious diseases in the Imperial College Healthcare NHS Trust.

Among his accolades, Professor Friedland can count the Royal College of Physicians Weber-Parkes Prize Medal. Awarded once every three years, this award recognises major contributions to the prevention and cure of TB. He was elected a Fellow of the Academy of Medical Sciences in 2008, a Fellow of Royal College of Physicians of Ireland in 2010 and an inaugural Fellow of The European Society of Clinical Microbiology and Infectious Diseases in 2017.

In addition, Professor Friedland is currently a Commissioner on The Commission for Human Medicines which advises government ministers on the safety, efficacy and quality of medicinal products and chairs the MHRA Expert Advisory Group on Infection. He has previously served on the Joint Committee on Vaccination and Immunisation and on the Chief Medical Officer’s National Expert Panel on New and Emerging Infections.